Why African local-currency debt is the year’s best EM story

African local-currency debt is having the best year in EM fixed income. Bond markets across the continent have returned 5.5% year-to-date versus 3.2% for broader emerging-market peers, with demand so strong that current supply cannot satisfy investor appetite, Vontobel Asset Management Portfolio Manager Carlos de Sousa said in a Bloomberg report published Thursday.

The country-level dispersion tells the actual story. Zambia’s local ZMW-denominated bonds have delivered a 36% return YTD in USD terms — more than any other emerging market Bloomberg tracks, per Citi’s late-July call. Nigerian government bonds are yielding around 21%, Ugandan bonds 16%, Zambian bonds 18%. Real yields across the continent’s high-yield names sit at some of the most attractive levels globally, backed by IMF programs, fiscal resets, and — in the cases of Nigeria, Ghana, and Zambia — structural reforms that have moved from theory to execution.

Why does this matter for Gulf SWFs? The LP base sitting on 2H 2026 EM debt deployment mandates has a clean alternative to hard-currency EM sovereign bonds that doesn’t require wagering on the Fed cycle. PIF, Mubadala, Adia, and QIA have historically anchored their EM debt exposure through USD-denominated sovereign paper — a trade that has become structurally harder to price under a Warsh Fed that shows no signs of cutting. African local-currency debt sidesteps the trade entirely. The returns come from local rates and currency appreciation against a softening greenback, not from spread compression on Fed easing that isn’t coming.

The trade also produces something the hard-currency market has struggled to offer this year — real returns commensurate with real risk, priced by domestic markets rather than mediated through the global USD liquidity cycle. WisdomTree’s analysis shows local-currency EM debt has surged toward 20% returns in early 2026, outpacing hard-currency peers closer to 15%, reversing a decade-long pattern in which USD-denominated EM debt outperformed by a wide margin.

Egypt is not excluded from this trade by geography — it is excluded by its own market structure. EGP-denominated debt yields sit in the same 15-20%+ tier as Ghana and Nigeria, but foreign investors buying Ghanaian or Zambian local-currency debt can generally sell and convert back to the greenback in normal conditions. In Egypt, that round-trip has been repeatedly disrupted by FX rationing, USD queues, and periodic sharp devaluations. That history means institutional investors typically cap their EGP allocations at a fraction of what they would deploy in an African peer with the same nominal yield.

Egypt’s Eurobond window — previously estimated at a clean 8-11% yield — was shut in the spring on the assumption of a Fed cut cycle that markets have since pushed further out. With CME FedWatch now showing a 64% probability of a September hold at 3.5% and no cuts priced through year-end, the pricing window needed hasn’t reopened.

The bottom line: African local-currency debt is the trade of the year in EM fixed income, and it is a trade that runs entirely outside the Fed cycle logic since April CPI. For Gulf SWF LPs deploying into 2H, the question is no longer where the yield is — it is whether their EM debt mandate allows them to take it in ZMW, NGN, and UGX rather than USD.

(** Tap or click the headline above to read this story with all of the links to our background as well as external sources.)

MARKETS THIS MORNING-

Asian markets showed little activity this morning, with Japan’s Nikkei dropping around 0.1%. MSCI’s broadest index of Asia-Pacific shares, excluding Japan, remained flat. South Korea’s stock market is closed today due to a national holiday.

THE CLOSING BELL-

The EGX30 rose 1.1% at yesterday’s close on turnover of EGP 13.5 bn (29.7% above the 90-day average). Local investors were the sole net buyers. The index is up 33.5% YTD.

In the green: Orascom Construction (+7.1%), Edita (+6.8%), and AMOC (+6.1%).

In the red: Valmore Holding -EGP (-3.7%), Rameda (-3.7%), and Ibnsina Pharma (-3.5%).